Etocarlide

Etocarlide

SCHEMBL359440

CCOc1ccc(NC(=S)Nc2ccc(OCC)cc2)cc1.[W]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.96
GAA P10253 5/20 0.83
L3MBTL1 Q9Y468 1/20 0.73
ALDH1A1 P00352 7/20 0.68
KDM4E B2RXH2 2/20 0.68
LMNA P02545 4/20 0.67
KMT2A Q03164 5/20 0.64
MEN1 O00255 3/20 0.64
POLB P06746 2/20 0.64
HTT P42858 2/20 0.64
NSD2 O96028 1/20 0.64
HPGD P15428 1/20 0.64
BLM P54132 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
MPI P34949 1/20 0.62
CYP1A2 P05177 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
PTGES O14684 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etocarlide SCHEMBL103618 0.98 MAPT (1.00) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL9263 0.98 MAPT (1.00) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL938885 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL20447982 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL1654904 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL5832656 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL20658914 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL21694441 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL20994029 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL522112 0.96 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106846-A1 METHOD FOR TUNGSTEN-BASED THIN FILM DEPOSITION VIA FABRICATION AND DECOMPOSITION OF PRECURSOR METASTABLE COMPLEXES (MOLECULAR SPECIES) KALARK NANOSTRUCTURE SCIENCES INC. (US) 2026-05-21 WO claimed
US-20260132506-A1 METHOD FOR TUNGSTEN-BASED THIN FILM DEPOSITION VIA FABRICATION AND DECOMPOSITION OF PRECURSOR METASTABLE COMPLEXES (MOLECULAR SPECIES) KALARK NANOSTRUCTURE SCIENCES INC (US) 2026-05-14 US claimed
CN-122010180-A Method for preparing rapid hydrogen-induced color mesoporous tungsten oxide film based on plasma etching technology 上海交通大学 2026-05-12 CN claimed
US-20250388995-A1 SYSTEMS AND METHODS FOR RECYCLING END-OF-LIFE BATTERY MATERIALS 24M TECH INC (US) 2025-12-25 US claimed
CN-119708910-A Ink and application thereof 广东聚华印刷显示技术有限公司 2025-03-28 CN claimed
CN-119684343-A Organic-inorganic hybrid material and preparation method and application thereof 中国科学院大连化学物理研究所 2025-03-25 CN claimed
EP-3882295-B1 METHOD FOR PREPARING POLYESTER POLYOL DALIAN INST CHEM & PHYSICS CAS (CN) 2025-03-19 EP claimed
CN-119627086-A Preparation method of metal oxide coated high-nickel ternary positive electrode material 郑州大学 2025-03-14 CN claimed
CN-119297225-A Ternary positive electrode material, preparation method thereof, positive electrode plate and secondary battery 天津巴莫科技有限责任公司 2025-01-10 CN claimed
CN-119212425-A Light-emitting device, preparation method thereof and display device 广东聚华印刷显示技术有限公司 2024-12-27 CN claimed
US-6955771-B2 Metal oxide sols as nanoscale additives for polymers APS LABORATORY (US) 2005-10-18 US claimed
WO-2005081789-A2 Formation of CIGS Absorber Layer by Atomic Layer Deposition NANOSOLAR, INC. (US) 2005-09-09 WO claimed
US-20050186342-A1 Elements of groups IB, IIIA, VIB formed by placing a substrate in a treatment chamber, performing atomic layer deposition of a group IB element and/or group IIIA elements from separate sources onto a substrate to form a film, group VIA element is then incorporated into the film; solar cell; lamination NANOSOLAR, INC. (US) 2005-08-25 US claimed
WO-2005035668-A2 PREPARATION OF METAL NANOPARTICLES AND NANOCOMPOSITES THEREFROM APS LABORATORY (US) 2005-04-21 WO claimed
US-6838486-B2 Preparation of metal nanoparticles and nanocomposites therefrom APS LABORATORY (US) 2005-01-04 US claimed
US-20040242740-A1 Metal oxide sols as nanoscale additives for polymers RYANG HONG-SON (US) 2004-12-02 US claimed
US-20040167257-A1 PREPARATION OF METAL NANOPARTICLES AND NANOCOMPOSITES THEREFROM APS LABORATORY 2004-08-26 US claimed
US-20040159824-A1 METAL OXIDE SOLS AS NANOSCALE ADDITIVES FOR POLYMERS APS LABORATORY 2004-08-19 US claimed
WO-2004063288-A1 METAL OXIDE SOLS AS NANOSCALE ADDITIVES FOR POLYMERS APS LABORATORY (US) 2004-07-29 WO claimed
US-20040042953-A1 Method of producing nanophase WC-based powder by vapor phase reaction at atmospheric pressure KOREA INSTITUTE OF MATERIALS SCIENCE (KR) 2004-03-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132506-A1 METHOD FOR TUNGSTEN-BASED THIN FILM DEPOSITION VIA FABRICATION AND DECOMPOSITION OF PRECURSOR METASTABLE COMPLEXES (MOLECULAR SPECIES) SOD1, WDR1, MCCC2 MAPT 577/4885GAA 3000/4885L3MBTL1 986/4885
US-20250388995-A1 SYSTEMS AND METHODS FOR RECYCLING END-OF-LIFE BATTERY MATERIALS WNT3A, WRN, L3MBTL3 MAPT 1547/4885GAA 681/4885L3MBTL1 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.